Expert Review of Endocrinology & Metabolism
Volume 16, 2021 - Issue 4
Drug profile
Levoketoconazole: a novel treatment for endogenous Cushing's syndrome
Maria Fleseriua Oregon Health and Science University, Department of Medicine, Division of Endocrinology, Diabetes and Clinical Nutrition, Department of Neurological Surgery, and Pituitary Center, Portland, USACorrespondence[email protected]
https://orcid.org/0000-0001-9284-6289View further author information
https://orcid.org/0000-0001-9284-6289View further author information, Richard J. Auchusb University of Michigan Medical School, Department of Internal Medicine and Department of Pharmacology, Ann Arbor, USAhttps://orcid.org/0000-0001-6815-6181View further author information
https://orcid.org/0000-0001-6815-6181View further author information, Rosario Pivonelloc Università Federico II Di Napoli, Dipartimento Di Medicina Clinica E Chirurgia, Sezione Di Endocrinologia, Naples, Italyhttps://orcid.org/0000-0002-9632-1348View further author information
https://orcid.org/0000-0002-9632-1348View further author information, Roberto Salvatorid Johns Hopkins University, Department of Medicine, Division of Endocrinology, and Pituitary Center, Baltimore, USAhttps://orcid.org/0000-0001-6495-2244View further author information
https://orcid.org/0000-0001-6495-2244View further author information, Sabina Zacharievae Medical University-Sofia, Department of Endocrinology, Sofia, Bulgariahttps://orcid.org/0000-0001-6087-7136View further author information
https://orcid.org/0000-0001-6087-7136View further author information & Beverly M. K. Billerf Massachusetts General Hospital, Neuroendocrine and Pituitary Tumor Clinical Center, Boston, USAhttps://orcid.org/0000-0003-4359-4622View further author information
https://orcid.org/0000-0003-4359-4622View further author information